Research in colorectal cancer has revealed that high-mobility group box 1 (HMGB1), engaging its receptor RAGE, activates the ERK1/2 pathway to phosphorylate and activate Drp1, thereby fostering chemoresistance. The gene discussed is HMGB1; the disease is colorectal cancer.